Sort
17,054 grants matching “genome editing”
(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression
$565,095Sidi Chen · Yale University · R01 · FY2022 · CA
Discovery of Functional Variants in Type 2 Diabetes Genes in Mexican Americans
$565,032Ravindranath Duggirala · University Of Texas Rio Grande Valley · U01 · FY2017 · DK
Discovery of Functional Variants in Type 2 Diabetes Genes in Mexican Americans
$565,032Ravindranath Duggirala · University Of Texas Rio Grande Valley · U01 · FY2016 · DK
Prostate Cancer Risk Enhancers
$564,927Peggy J Farnham · University Of Southern California · R01 · FY2016 · CA
RNA METABOLISM IN TRYPANOSOMES
$564,904Yale University · R01 · FY2000 · AI
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction
$564,836Yigang Wang · University Of Cincinnati · R01 · FY2024 · HL
Dynamic Nuclear Polarization MR Spectroscopic Imaging for Diagnosis and Treatment Response Assessment in Hepatocellular Carcinoma
$564,809Terence P Gade · University Of Pennsylvania · R01 · FY2025 · CA
Down Syndrome: a potential treatment XISTs
$564,755Volney L Sheen · Beth Israel Deaconess Medical Center · R01 · FY2025 · HD
Systems Immunogenetics of Influenza Virus Infection in the Collaborative Cross
$564,671Mark T Heise · Univ Of North Carolina Chapel Hill · U19 · FY2020 · AI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross
$564,671Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2020 · AI
Molecular mechanisms of synaptic dysfunction and cognitive decline in Huntington's disease
$564,609Rocio Gomez-Pastor · University Of Minnesota · R01 · FY2025 · NS
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects
$564,433Alexander A Soukas · Massachusetts General Hospital · R01 · FY2022 · AG
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects
$564,432Alexander A Soukas · Massachusetts General Hospital · R01 · FY2020 · AG
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects
$564,432Alexander A Soukas · Massachusetts General Hospital · R01 · FY2021 · AG
Improving response durability after CAR T cell therapy for multiple myeloma
$564,221Michael C. Milone · University Of Pennsylvania · P01 · FY2025 · CA
Systematic Functional Interpretation of Regulatory Variants in Schizophrenia
$564,209Jubao Duan · Endeavor Health Clinical Operations · R01 · FY2016 · MH
Chromosome 17q21, allergic inflammation, and remodeling
$564,143David H Broide · University Of California, San Diego · R01 · FY2022 · AI
Discovery of Somatic Noncoding Variants that Serve as Drivers in Pediatric Cancers
$564,115Jinghui Zhang · St. Jude Children'S Research Hospital · R01 · FY2020 · CA
Discovery of Somatic Noncoding Variants that Serve as Drivers in Pediatric Cancers
$564,115Jinghui Zhang · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Tafazzin and metabolic reprogramming during cardiomyopathy
$564,058Simon J Conway · Indiana University Indianapolis · R01 · FY2023 · HL
Tafazzin and metabolic reprogramming during cardiomyopathy
$564,058Simon J Conway · Indiana University Indianapolis · R01 · FY2022 · HL
Project 2: Normal Cell Evolution
$563,917Darryl K Shibata · Arizona State University-Tempe Campus · U54 · FY2020 · CA
Development and characterization of mouse models of RP59 DHDDS deficiency
$563,818Steven J Pittler · University Of Alabama At Birmingham · R01 · FY2018 · EY
Analysis of cancer cell metabolism in diverse environmental conditions
$563,778Dennis Vitkup · Columbia University Health Sciences · R01 · FY2019 · CA
Therapeutic Potential of Base Editing Strategies to Convert CAG to CAA in Huntington's Disease
$563,700Jong-Min Lee · Massachusetts General Hospital · R01 · FY2025 · NS